Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)
PublisherNature Publishing Group
MetadataShow full item record
AbstractThe Supplementary Information originally published with this Article was an older version, in which 'IFN-γ' was misspelled 'INF-γ' in Supplementary Fig. 9 and the ?-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.
Author correction in 2020: In the version of this Article originally published, in Fig. 5j, the image labelled ‘siNT@NPs’ was incorrect. The correct Fig. 5j is shown below and has been updated in the online versions of the Article.(Figure presented.). DOI: 10.1038/s41565-020-0635-3
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85062595915&doi=10.1038%2fs41565-019-0417-y&partnerID=40&md5=81df85bee1ecbaf1b9f0e93c65cca253; http://hdl.handle.net/10713/10732; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078618954&doi=10.1038%2fs41565-020-0635-3&partnerID=40&md5=8660ee556ac6f7999603a2bd2d08d645